All lobbying filings

ESSILORLUXOTTICA USA INC.

Lobbying for ESSILORLUXOTTICA USA INC. · Vision care and eyewear.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $150,000.00 expenses · posted Apr 8, 2026

Official filing document

Bills named in this filing 2

HR 1521
DOC Access Act of 2025
S 1716
Vision Lab Choice Act of 2025

Lobbying activity 1

Health Issues

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; Issues related to Myopia education; Government Accountability Office Report; Tariffs; US-Mexico-Canada Trade Agreement; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.